{"id":"NCT00000136","sponsor":"Johns Hopkins Bloomberg School of Public Health","briefTitle":"Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)","officialTitle":"Foscarnet-Ganciclovir CMV Retinitis Trial","status":"COMPLETED","phase":"PHASE3","dates":{"start":"1990-03","primaryCompletion":"1991-10","completion":"1991-10","firstPosted":"1999-09-24","resultsPosted":"2015-10-22","lastUpdate":"2015-10-22"},"enrollment":234,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections","Cytomegalovirus Retinitis"],"interventions":[{"type":"DRUG","name":"Foscarnet","otherNames":["Foscavir"]},{"type":"DRUG","name":"Ganciclovir","otherNames":["Vitraset"]}],"arms":[{"label":"Foscarnet","type":"EXPERIMENTAL"},{"label":"Ganciclovir","type":"EXPERIMENTAL"}],"summary":"To evaluate the relative safety and efficacy of ganciclovir and foscarnet as initial treatment of patients with cytomegalovirus (CMV) retinitis.","primaryOutcome":{"measure":"Mortality","timeFrame":"All patients enrolled will be followed until a common study closing date, which was chosen to provide a minimum of 1 year of follow-up for all patients enrolled in the trial.","effectByArm":[{"arm":"Foscarnet","deltaMin":107,"sd":null},{"arm":"Ganciclovir","deltaMin":127,"sd":null}],"pValues":[]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":4},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["1315661","8660161","8660169","8660168","9207349","9262538","9222234","1345799","8035989","7658051","7802522","9330549","10980764"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":60,"n":107},"commonTop":[]}}